Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies are working hard to make advancements that can help patients. Stem cells ...
Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic disorders. Now, a clinical trial reports that a single dose can ...
On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the ...
Zemcelpro(R) (dorocubicel) achieved remarkable and clinically meaningful survival results in patients with high- and very high-risk acute leukemias and myelodysplastic syndromes -- Topline results ...
Master is associate professor in the Department of Social Sciences and Health Policy at Wake Forest University School of Medicine and associate director of Wake Forest University’s Center for ...
Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
Neurodegenerative diseases like Parkinson's and Alzheimer's are characterized by irreversible neuron damage and limited natural repair mechanisms. While stem cell therapy holds great promise for ...
NeuroScientific Biopharmaceuticals has begun transferring the production of stem cells for its StemSmart therapy to Q-Gen in Brisbane, ahead of Crohn’s disease clinical trials.
US FDA clears Unixell Biotech’s IND for allogeneic iPSC-derived cell therapy, UX-GIP001 for focal epilepsy: Shanghai Monday, March 16, 2026, 17:00 Hrs [IST] Shanghai UniXell Bio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results